products often lack quality control, raising fears of contamination, incorrect dosing, or dangerous ingredients, with the FDA warning against compounding it due to insufficient safety data
Spesso studiati insieme Composti correlati
Similar content being viewed by others Introduction Exposure to aromatic amines (AA) is of concern in pharmaceutical development, as well as in occupational and wider environmental contexts, due to their potential toxicities
Finally, a four-year, multicenter, clinical trial in 421 diabetic patients with distal symmetric sensorimotor polyneuropathy found no difference between oral administration of 600 mg/day of lipoic and placebo on the primary endpoint, a composite score that assessed neuropathic impairment of the lower limbs and nerve conduction (78)
It also allows the reversal of signs of aging by decreasing the appearance of already formed wrinkles from the skin
Staff raised concerns about incomplete characterization, manufacturing-related impurities, aggregation and immune reactions, limited clinical evidence, uncertain effectiveness, and gaps in long-term safety data